Jeffrey Avins Glassberg MD
Instructor, Emergency Medicine, Icahn School of Medicine
Join to View Full Profile
10 E 102nd StNew York, NY 10029
Phone+1 212-241-6756
Fax+1 212-423-0522
Dr. Glassberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineResidency, Emergency Medicine, 2006 - 2010
Washington University in St. Louis School of MedicineClass of 2006
Certifications & Licensure
NY State Medical License 2008 - 2027
FL State Medical License 2015 - 2017
American Board of Emergency Medicine Emergency Medicine
Clinical Trials
- Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I Start of enrollment: 2010 Sep 01
- Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease Start of enrollment: 2014 Mar 01
- Comparing Acute Pain Management Protocols for Patients With Sickle Cell Disease Start of enrollment: 2015 Mar 15
- Join now to see all
Publications & Presentations
PubMed
- Epidemiology of Intensive Care Use for Patients With Sickle Cell Disease in New York State.Miguel Eduardo Cid, Zhixin Yang, Jeffrey Glassberg, Sarah McCuskee, May Hua
Chest. 2025-08-01 - User Perceptions of a Multilevel mHealth Intervention to Boost Adherence to Hydroxyurea in Sickle Cell Disease.Christina M Abrams, Natalia Davila, Sherif M Badawy, Maura M Kepper, Robert W Gibson
Pediatric Blood & Cancer. 2025-07-01 - Buprenorphine Is Associated With Lower Home Opioid Use and Acute Care Utilization in Sickle Cell Disease.Charleen Jacobs-McFarlane, Angela Liu, Brittany McCrary, Sarah McCuskee, Mikayla Gordon Wexler
Pain Management Nursing. 2025-05-29
Press Mentions
New Sickle Cell Treatments Reach Patients After Years of EffortOctober 1st, 2024
ED Management of Sickle Cell Vaso-Occlusive Crises: Myths, Facts, and A Novel Approach to Acute Pain ManagementApril 15th, 2019
Mount Sinai Receives NIH Grant to Study Use of Inhaled Corticosteroids for Sickle Cell TreatmentAugust 14th, 2018- Join now to see all
Grant Support
- "REAL Answers" (Registry Expansion Analyses to Learn)ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2028
- SCD REVIVE - Retina to Evaluate Vaso occlusion In the Vasculature of the EyeICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
